#8 of pharma imports · Other bulk drugs
Insulin & salts: imports into India
Tariff line 29371200 · CAS 9004-10-8
Imports 2025-26
2 t
-9.1% vs 2024-25
Import bill (CIF, before duty)
₹425 cr
Volume growth, 2020-21 to 2025-26
+17.3% a year
Rising
Net imports 2025-26
0.3 t
Exports 2 t
Import volume by financial year
RisingShow as table
| Year | Imports | Import bill |
|---|---|---|
| 2020-21 | 0.9 t | ₹183 cr |
| 2021-22 | 2.9 t | ₹241 cr |
| 2022-23 | 1.7 t | ₹243 cr |
| 2023-24 | 2.1 t | ₹292 cr |
| 2024-25 | 2.2 t | ₹285 cr |
| 2025-26 | 2 t | ₹425 cr |
Where it comes from (2025-26)
Share of the import bill
- Denmark39%
- Malaysia17.7%
- Singapore12%
What's changing
- Science minister Jitendra Singh said domestic insulin manufacturing remains relatively limited and called for India-led scale-up of biosimilar insulin.Indian Pharma Post, 5 Apr 2026
Reported facts with their source. Not a forecast.
Buy or supply insulin & salts in India
Source: Export Import Data Bank, Department of Commerce (DGCI&S data), as published on 10 Nov 2026. The import bill is the total declared value, not a price per kg. How to read these figures.